Profil
Zvi Ioav Cabantchik is the founder of Aferrix Ltd.
(founded in 2002) and holds the title of Director.
He is currently a Professor at The Hebrew University of Jerusalem since 1979.
His former position was as Principal at Scots College Charitable Trust from 2006 to 2009.
Dr. Cabantchik's education includes an undergraduate degree from The Hebrew University of Jerusalem in 1965, a graduate degree from The Hebrew University of Jerusalem in 1966, and a doctorate degree from the University of Rochester Medical Center in 1974.
Postes actifs de Zvi Ioav Cabantchik
Sociétés | Poste | Début |
---|---|---|
Aferrix Ltd.
Aferrix Ltd. Medical SpecialtiesHealth Technology Aferrix Ltd. develops tools for early diagnosis and monitoring of toxic iron in the serum. The firm offers iron testing services and kits for research and treatment centers that specialize in iron over load diseases (thalassemia, hemochromatosis, myelodysplastic syndrome) and to pharmaceutical companies that are developing iron chelators. Its products include FeROS eLPI and FeROS LPI. The company was founded by Zvi Ioav Cabantchik and Alexander Silberman on February 10, 2002 and is headquartered in Tel Aviv, Israel. | Fondateur | 10/02/2002 |
The Hebrew University of Jerusalem | Corporate Officer/Principal | 01/01/1979 |
Anciens postes connus de Zvi Ioav Cabantchik
Sociétés | Poste | Fin |
---|---|---|
Scots College Charitable Trust | Corporate Officer/Principal | 01/01/2009 |
Formation de Zvi Ioav Cabantchik
The Hebrew University of Jerusalem | Undergraduate Degree |
University of Rochester Medical Center | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Aferrix Ltd.
Aferrix Ltd. Medical SpecialtiesHealth Technology Aferrix Ltd. develops tools for early diagnosis and monitoring of toxic iron in the serum. The firm offers iron testing services and kits for research and treatment centers that specialize in iron over load diseases (thalassemia, hemochromatosis, myelodysplastic syndrome) and to pharmaceutical companies that are developing iron chelators. Its products include FeROS eLPI and FeROS LPI. The company was founded by Zvi Ioav Cabantchik and Alexander Silberman on February 10, 2002 and is headquartered in Tel Aviv, Israel. | Health Technology |
Scots College Charitable Trust |